Key result
Fewer cardiometabolic comorbidities in cardiac sarcoidosis are linked to higher ventricular arrhythmia prevalence.
Why the study?
Although studies have investigated types of cardiac sarcoidosis based on imaging and genetics, no studies have described the clinical heterogeneity of patients with cardiac sarcoidosis.
Observational (n=848)
Yes
Cardiac sarcoidosis patients can be classified into three distinct clinical phenotypes based on comorbidities, which correlate with different risks for ventricular arrhythmias and acute respiratory failure.
Background Sarcoidosis is a systemic granulomatous disease with cardiac involvement reported in 20–27% of patients [1]. Cardiac sarcoidosis (CS) can lead to atrial or ventricular arrhythmias, various conduction system disorders, heart failure or sudden cardiac death, depending on the location of myocardial involvement [2]. Previous studies have investigated the possible types of CS based on the distribution of myocardial involvement on imaging as well as the role of genetic factors [3,4]. However, there are no studies describing the clinical heterogeneity of CS patients. Purpose In order to determine if clinical clusters exist in CS, we carried out a latent class analysis (LCA) to explore potential phenotypes in a large sample of CS patients from the National Inpatient Sample (NIS). Methods We identified 848 patients with a diagnosis of CS from the NIS in 2016–2018. A LCA was performed based on comorbidities. Utilizing the Bayesian information criterion and Akaike's information criterion we divided our study population into 3 cohorts. We subsequently applied the LCA model for our study population to fit each patient into one of the 3 cohorts. Finally, we compared the clinical outcomes among the 3 groups. Results Following LCA, patients in cohort 3 were strongly associated with a cardiometabolic syndrome profile with the highest prevalence of congestive heart failure (CHF, 95.1%), chronic kidney disease (CKD, 69.7%), diabetes mellitus (68.9%), hyperlipidemia (52.5%) and obesity (45.1%). Patients in cohort 2 had an intermediate prevalence of cardiometabolic syndrome with a universal diagnosis of hypertension (100%) but with the lowest number of CHF (32.5%) patients and none with CKD. Finally, patients in cohort 1 had the least comorbidities in comparison to the other groups but there was a higher prevalence of CHF (71.7%). There was no significant difference in mortality among the 3 groups, but acute respiratory failure was the highest in cohort 3. However, ventricular arrhythmias were more prevalent in cohort 1 patients (Table). Conclusion We identified 3 different types of CS based on their clinical phenotype. The clinical outcomes varied among the cohorts with ventricular arrhythmias being the most prevalent in patients with the least cardiometabolic comorbidities.
No takes yet. Share an insight, caveat, or question.
Dai et al. (2021) conducted an observational in Cardiac sarcoidosis (n=848). Clinical phenotypes (Latent Class Analysis cohorts) vs. Between-cohort comparison was evaluated on Clinical outcomes including mortality, acute respiratory failure, and ventricular arrhythmias. Latent class analysis identified 3 clinical phenotypes of cardiac sarcoidosis, with ventricular arrhythmias being most prevalent in patients with the least cardiometabolic comorbidities.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from European Heart Journal